Sandoz Multimedia
Visit our multimedia gallery to learn about Sandoz.
Sandoz US News
Sandoz introduces authorized generic version of Clobex® Shampoo, 0.05%
Sandoz today announced the introduction of clobetasol propionate shampoo, 0.05%, an authorized generic version of Clobex® Shampoo, 0.05%, in the US.
- Read more
- January 03, 2012
Featured Products
-
enoxaparin sodium injection (Lovenox®)
With its launch of enoxaparin in July 2010, Sandoz was the first company to offer patients in the US a generic version of Lovenox®, which has been called the 'gold standard' of anti-thrombotic medicines.
-
amlodipine besylate/benazepril capsules (Lotrel®)
Sandoz's amlodipine benazepril is an authorized generic equivalent of Lotrel®, a hypertension medicine that is currently marketed by Sandoz parent company Novartis Pharmaceuticals Corporation.
Product Finder
Use our product finder tool to search our database for information regarding a specific Sandoz product in the US.
Quick Links
Click below for important links.
Sandoz Careers
Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.
-
Sandoz in the US
Sandoz in the US
A Healthy Decision
Sandoz is a world leader in generic pharmaceuticals, providing access to a wide array of high-quality, affordable medicines. In the US, Sandoz markets approximately 200 different generic drugs, including enoxaparin sodium injection, the first generic version of Lovenox®, and Omnitrope®, the groundbreaking follow-on biologic. Our 1,300 US associates, are proud to make Sandoz a “healthy decision”. Learn more about Sandoz in the US
-
Quality
Quality
Everyone Can Afford
As part of the Novartis group, we believe that superior quality is the key to our long-term success. Our state-of-the-art technologies, decades of experience, and rigorous across-the-board quality standards all contribute to our broad portfolio of premium quality generic medicines. Learn more about our Quality Standards
-
Complex Medicines
Differentiation
Shaping the Future of Healthcare
We use innovation and expertise to go beyond standard generics and develop even the most complex medicines that add value to patient healthcare – from biosimilars and complex injectables, to respiratory and specialty generics. Patient access to cost-effective treatment: this is how we are shaping the future of patient healthcare. Learn more about our Products
-
Biosimilars
Pioneering Biosimilars
The Market of the Future
Sandoz was the first company to develop and market follow-on versions of highly complex biopharmaceuticals. Today, we are the undisputed global leader in this segment and have an industry-leading pipeline that will make essential biopharmaceuticals more affordable for all. Discover Sandoz Biosimilars
